Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-22

Clinical Trial Update: Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients [Phase 1]

View source ↗

Summary

A Phase 1 safety study of the Ventricular Partitioning Device Implant System for heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ventricular Partitioning Device Implant System

Snippet

Sponsor: CardioKinetix, Inc | Conditions: Heart Failure | Phase 1 | Status: COMPLETED